JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

JNJ

227.46

-1.06%↓

UNH

369.01

-0.49%↓

TMO

469.28

-1.91%↓

ISRG

457.59

+0.02%↑

ABT

89.51

-1.34%↓

Search

ResMed Inc

Closed

SectorHealthcare

204.48 -4.11

Overview

Share price change

24h

Current

Min

204.31

Max

206.46

Key metrics

By Trading Economics

Income

44M

393M

Sales

87M

1.4B

P/E

Sector Avg

21.982

67.147

Dividend yield

1.03

Profit margin

27.593

Employees

10,600

EBITDA

63M

566M

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+32.18% upside

Dividends

By Dow Jones

Dividend yield

Sector Avg

1.03%

2.36%

Next Earnings

30 Jul 2026

Next Dividend date

18 Jun 2026

Next Ex Dividend date

14 May 2026

Market Stats

By TradingEconomics

Market Cap

-4.9B

32B

Previous open

208.59

Previous close

204.48

News Sentiment

By Acuity

32%

68%

77 / 347 Healthcare

ResMed Inc Chart

Past performance is not a reliable indicator of future results.

Related News

3 May 2026, 23:47 UTC

Earnings

National Australia Bank Warns of Economic Shock as 1st Half Profit Falls -- Update

3 May 2026, 22:35 UTC

Earnings

National Australia Bank Holds Dividend Despite 19% 1st Half Profit Drop

3 May 2026, 23:39 UTC

Market Talk

Gold Edge Higher Amid Signs of Resilience -- Market Talk

3 May 2026, 23:34 UTC

Market Talk

Oil Declines Amid Mild Risk-on Sentiment -- Market Talk

3 May 2026, 23:32 UTC

Earnings

National Australia Bank Warns of Economic Shock as 1H Profit Falls -- Update

3 May 2026, 23:30 UTC

Market Talk

Nickel Industries Result Shows Power of Higher Prices -- Market Talk

3 May 2026, 23:20 UTC

Market Talk

RBA Likely to Hike Rates; Guidance and Board Split Key -- Market Talk

3 May 2026, 23:16 UTC

Acquisitions, Mergers, Takeovers

GameStop Is Offering to Buy eBay for $56 Billion, CEO Ryan Cohen Says -- WSJ

3 May 2026, 22:57 UTC

Acquisitions, Mergers, Takeovers

GameStop Is Offering to Buy eBay For $56 Billion, CEO Ryan Cohen Says -- WSJ

3 May 2026, 22:57 UTC

Acquisitions, Mergers, Takeovers

GameStop Has Roughly 5% Stake in eBay, Cohen Says -- WSJ

3 May 2026, 22:57 UTC

Acquisitions, Mergers, Takeovers

GameStop Offering to Buy eBay for $125 a Share, or About $56 Billion, CEO Ryan Cohen Says -- WSJ

3 May 2026, 22:57 UTC

Acquisitions, Mergers, Takeovers

GameStop Is Prepared to Run Proxy Fight If eBay Isn't Receptive to a Deal, Cohen Says -- WSJ

3 May 2026, 22:57 UTC

Acquisitions, Mergers, Takeovers

GameStop Has Around $20 Billion in Debt Financing Committed From TD Bank, Cohen Says -- WSJ

3 May 2026, 22:45 UTC

Market Talk

Global Equities Roundup: Market Talk

3 May 2026, 22:45 UTC

Market Talk

Low-Cost Miners in Spotlight Amid High Energy Prices -- Market Talk

3 May 2026, 22:20 UTC

Earnings

National Australia Bank Holds Dividend Despite 19% 1H Profit Drop

3 May 2026, 22:08 UTC

Earnings

NAB's 1H Included Previously Announced A$1.35B Software Amortization Charge>NAB.AU

3 May 2026, 22:05 UTC

Earnings

NAB 1H Net Interest Income A$9.16B Vs. A$8.445B>NAB.AU

3 May 2026, 22:05 UTC

Earnings

NAB 1H Credit Impairment Charge A$706M Vs. A$348M>NAB.AU

3 May 2026, 22:05 UTC

Earnings

NAB 1H Operating Expenses A$5.02B Vs. A$4.81B>NAB.AU

3 May 2026, 22:04 UTC

Earnings

NAB 1H Net Interest Margin 1.81%>NAB.AU>NAB.AU

3 May 2026, 22:03 UTC

Earnings

NAB 1H Cash Return on Equity Ex-Large Notable Items 11.6%>NAB.AU

3 May 2026, 22:03 UTC

Earnings

NAB 1H Cash Return on Equity 8.5%>NAB.AU

3 May 2026, 22:02 UTC

Earnings

NAB 1H CET1 Capital Ratio 11.65% Vs. 12.01%>NAB.AU

3 May 2026, 22:02 UTC

Earnings

NAB 1H Cash Earnings A$2.64B>NAB.AU

3 May 2026, 22:02 UTC

Earnings

NAB 1H Cash Earnings Ex-Notable Items A$3.59B Vs. A$3.58B>NAB.AU

3 May 2026, 22:01 UTC

Earnings

National Australia Bank Keeps Dividend at A$0.85 >NAB.AU

3 May 2026, 22:01 UTC

Earnings

National Australia Bank 1H Rev A$11.16B Vs. A$10.28B >NAB.AU

3 May 2026, 22:01 UTC

Earnings

National Australia Bank 1H Net A$2.75B Vs. Net A$3.41B >NAB.AU

3 May 2026, 15:06 UTC

Earnings

Berkshire's Greg Abel Marks His First Annual Meeting as CEO. We'd Give Him a B-Plus. -- Barrons.com

Peer Comparison

Price change

ResMed Inc Forecast

Price Target

By TipRanks

32.18% upside

12 Months Forecast

Average 271 USD  32.18%

High 340 USD

Low 225 USD

Based on 12 Wall Street analysts offering 12 month price targets forResMed Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

12 ratings

8

Buy

4

Hold

0

Sell

Sentiment

By Acuity

77 / 347 Healthcare

News Sentiment

Bullish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

$

About ResMed Inc

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; and NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry over several nights. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
help-icon Live chat